BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1060 related articles for article (PubMed ID: 26892084)

  • 21. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
    Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
    Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
    JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal Implantation Depth and Adherence to Guidelines on Permanent Pacing to Improve the Results of Transcatheter Aortic Valve Replacement With the Medtronic CoreValve System: The CoreValve Prospective, International, Post-Market ADVANCE-II Study.
    Petronio AS; Sinning JM; Van Mieghem N; Zucchelli G; Nickenig G; Bekeredjian R; Bosmans J; Bedogni F; Branny M; Stangl K; Kovac J; Schiltgen M; Kraus S; de Jaegere P
    JACC Cardiovasc Interv; 2015 May; 8(6):837-846. PubMed ID: 25999108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves.
    Toggweiler S; Wood DA; Rodés-Cabau J; Kapadia S; Willson AB; Ye J; Cheung A; Leipsic J; Binder RK; Gurvitch R; Freeman M; Thompson CR; Svensson LG; Dumont E; Tuzcu EM; Webb JG
    JACC Cardiovasc Interv; 2012 May; 5(5):571-577. PubMed ID: 22625197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical Trial.
    Reardon MJ; Feldman TE; Meduri CU; Makkar RR; O'Hair D; Linke A; Kereiakes DJ; Waksman R; Babliaros V; Stoler RC; Mishkel GJ; Rizik DG; Iyer VS; Gleason TG; Tchétché D; Rovin JD; Lhermusier T; Carrié D; Hodson RW; Allocco DJ; Meredith IT;
    JAMA Cardiol; 2019 Mar; 4(3):223-229. PubMed ID: 30810703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
    Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The aortic valve calcium nodule score (AVCNS) independently predicts paravalvular regurgitation after transcatheter aortic valve replacement (TAVR).
    Azzalini L; Ghoshhajra BB; Elmariah S; Passeri JJ; Inglessis I; Palacios IF; Abbara S
    J Cardiovasc Comput Tomogr; 2014; 8(2):131-40. PubMed ID: 24661826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).
    Blackman DJ; Meredith IT; Dumonteil N; Tchétché D; Hildick-Smith D; Spence MS; Walters DL; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Houle VM; Allocco DJ; Dawkins KD
    Am J Cardiol; 2017 Jul; 120(2):292-299. PubMed ID: 28535962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transapical transcatheter aortic valve implantation: follow-up to 3 years.
    Ye J; Cheung A; Lichtenstein SV; Nietlispach F; Albugami S; Masson JB; Thompson CR; Munt B; Moss R; Carere RG; Jamieson WR; Webb JG
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1107-13, 1113.e1. PubMed ID: 20412948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery.
    Reardon MJ; Adams DH; Coselli JS; Deeb GM; Kleiman NS; Chetcuti S; Yakubov SJ; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Khabbaz K; Tadros P; Zorn GL; Merhi W; Heiser J; Petrossian G; Robinson N; Maini B; Mumtaz M; Lee JS; Gleason TG; Resar J; Conte J; Watson D; Chenoweth S; Popma JJ;
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2869-76.e1-7. PubMed ID: 25152474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
    Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
    J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
    Deeb GM; Chetcuti SJ; Reardon MJ; Patel HJ; Grossman PM; Schreiber T; Forrest JK; Bajwa TK; O'Hair DP; Petrossian G; Robinson N; Katz S; Hartman A; Dauerman HL; Schmoker J; Khabbaz K; Watson DR; Yakubov SJ; Oh JK; Li S; Kleiman NS; Adams DH; Popma JJ
    JACC Cardiovasc Interv; 2017 May; 10(10):1034-1044. PubMed ID: 28521921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve.
    Treede H; Tübler T; Reichenspurner H; Grube E; Pascotto A; Franzen O; Mueller R; Low R; Bolling SF; Meinertz T; Schofer J
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):897-903. PubMed ID: 20392455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study.
    Meredith IT; Worthley SG; Whitbourn RJ; Antonis P; Montarello JK; Newcomb AE; Lockwood S; Haratani N; Allocco DJ; Dawkins KD
    EuroIntervention; 2014 Mar; 9(11):1264-70. PubMed ID: 24169077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-Procedural Hemodynamic Status Improves the Discriminatory Value of the Aortic Regurgitation Index in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Sinning JM; Stundl A; Pingel S; Weber M; Sedaghat A; Hammerstingl C; Vasa-Nicotera M; Mellert F; Schiller W; Kovac J; Welz A; Grube E; Werner N; Nickenig G
    JACC Cardiovasc Interv; 2016 Apr; 9(7):700-11. PubMed ID: 27056309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial.
    Asch FM; Vannan MA; Singh S; Khandheria B; Little SH; Allocco DJ; Meredith IT; Feldman TE; Reardon MJ; Weissman NJ
    Circulation; 2018 Jun; 137(24):2557-2567. PubMed ID: 29530883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the geometric interaction between the Lotus transcatheter aortic valve prosthesis and the native ventricular aortic interface by 320-multidetector computed tomography.
    Gooley RP; Cameron JD; Meredith IT
    JACC Cardiovasc Interv; 2015 Apr; 8(5):740-9. PubMed ID: 25946448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.